Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.

If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

During acute episodes, patients may experience psychotic symptoms that impair their ability to control thoughts, emotions and ...

The effect of Caplyta was measured using a rating scale that evaluates how severe schizophrenia symptoms are. Higher scores mean more severe symptoms. Most people had severe symptoms of ...

The following is a summary of “Management of Psychosis and Schizophrenia by Primary Care GPs: A Cross-Sectional Study in ...

Schizophrenia is a chronic and severe mental disorder characterized by disruptions in thinking, emotions, perceptions, and behavior. People with schizophrenia may experience hallucinations ...

In this review the terms psychosocial interventions and psychosocial treatment are used interchangeably to refer to nonpharmacologic interventions designed to decrease symptom severity or distress ...

Among 196 doctors who prescribed clozapine, 64% said the positive aspects of the REMS certification process outweighed the ...

and those with severe head injury. Medscape Medical News, June 18, 2024 Cat Scratch Fever Pathogen Linked to Schizophrenia Adults with psychosis were three times more likely to have evidence of ...

FDA convened a joint meeting of its Drug Safety and Risk Management Advisory Committee and the Psychopharmacologic Drugs ...